Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CRSPCRISPR Therapeutics AG

Nasdaq · CIK 0001674416
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts307

Identity from submissions API

NameCRISPR Therapeutics AG
CIK0001674416
TickersCRSP
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2836 Biological Products, (No Diagnostic Substances)
EIN473173478
LEI—
Fiscal year end1231
State of incorporationV8 Switzerland
Phone6173154600
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • CRISPR Therapeutics AG (2016-05-13T00:00:00.000Z → 2026-11-19T00:00:00.000Z)
Business address
BAARERSTRASSE 14
ZUG
Switzerland
V8
Mailing address
BAARERSTRASSE 14
ZUG
Switzerland
V8

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

886 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 4 4 0001193125-26-468849 4534
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000940594-26-000069 005-89674 261557610 34 10642
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-126825 005-89674 261550644 34 13010
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000637 005-89674 261537868 34 8037
2026-11-06 144 xsl144X01/primary_doc.xml 0001950047-26-010798 001-37923 261533184 33 9378
2026-11-06 4 4 0001193125-26-452143 8084
2026-11-02 3 3 0001193125-26-443954 19018
2026-11-02 10-Q 10-Q 0001193125-26-443665 001-37923 261512449 34 10917919 1 1
2026-11-02 8-K 8-K 2.02,9.01 0001193125-26-443644 001-37923 261512375 34 423139 1 1
2026-10-28 4 4 0001193125-26-436444 8055
2026-10-28 4 4 0001193125-26-436443 8060
2026-10-28 4 4 0001193125-26-436441 8054
2026-10-28 4 4 0001193125-26-436436 8045
2026-10-21 4 4 0001193125-26-428010 5564
2026-10-21 3 3 0001193125-26-428002 46764
2026-10-20 4 4 0001193125-26-426878 9002
2026-10-19 8-K 8-K 5.02,9.01 0001193125-26-425243 001-37923 261469141 34 355279 1 1
2026-10-16 4 4 0001193125-26-424317 13074
2026-10-15 4 4 0001193125-26-423057 8930
2026-10-15 4 4 0001193125-26-423056 8923
2026-10-14 144 xsl144X01/primary_doc.xml 0001950047-26-010218 001-37923 261460140 33 4694
2026-10-08 4 4 0001193125-26-418101 8963
2026-10-06 144 xsl144X01/primary_doc.xml 0001950047-26-010087 001-37923 261444641 33 5465
2026-09-24 4 4 0001193125-26-401237 9144
2026-09-22 144 xsl144X01/primary_doc.xml 0001950047-26-009755 001-37923 261397324 33 4783
2026-09-21 4 4 0001193125-26-396944 9843
2026-09-21 4 4 0001193125-26-396935 7031
2026-09-17 144 xsl144X01/primary_doc.xml 0001950047-26-009604 001-37923 261386913 33 4638
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000940594-26-000049 005-89674 261279330 34 10571
2026-08-11 4 4 0001193125-26-345111 4543
2026-08-03 10-Q 10-Q 0001193125-26-330672 001-37923 261233437 34 10360329 1 1
2026-08-03 8-K 8-K 2.02,9.01 0001193125-26-330644 001-37923 261233299 34 417344 1 1
2026-07-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002146 005-89674 261206014 34 11117
2026-06-09 4 4 0001193125-26-264390 5646
2026-06-09 4 4 0001193125-26-264382 5568
2026-06-09 4 4 0001193125-26-264290 5619
2026-06-09 4 4 0001193125-26-264289 5634
2026-06-09 4 4 0001193125-26-264288 5639
2026-06-09 4 4 0001193125-26-264287 5614
2026-06-09 4 4 0001193125-26-264286 5617
2026-06-09 4 4 0001193125-26-264285 5642
2026-06-09 4 4 0001193125-26-264282 5624
2026-06-09 4 4 0001193125-26-264279 5631
2026-06-05 S-8 S-8 0001193125-26-258473 333-296519 261066922 33 387544 1 1
2026-06-04 8-K 8-K 5.02,5.03,5.07,9.01 0001193125-26-257593 001-37923 261065670 34 1606178 1 1
2026-06-02 4 4 0001193125-26-253929 5561
2026-06-02 4 4 0001193125-26-253926 5542
2026-06-02 4 4 0001193125-26-253925 5539
2026-06-01 4 4 0001193125-26-251817 8961
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000940594-26-000027 005-89674 26985059 34 10570
2026-05-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001422849-26-000051 005-89674 26977705 34 7316
2026-05-04 10-Q 10-Q 0001193125-26-204188 001-37923 26938616 34 9401879 1 1
2026-05-04 8-K 8-K 2.02,9.01 0001193125-26-204147 001-37923 26938495 34 353085 1 1
2026-04-30 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-052492 005-89674 26922296 34 13380
2026-04-21 ARS ARS 0001193125-26-165183 001-37923 26876801 34 3292093
2026-04-21 DEFA14A DEFA14A 0001193125-26-165164 001-37923 26876789 34 13154576 1 1
2026-04-21 DEF 14A DEF 14A 0001193125-26-165158 001-37923 26876778 34 15773928 1 1
2026-04-02 PRE 14A PRE 14A 0001193125-26-140224 001-37923 26834008 34 13922413 1 1
2026-03-24 4 4 0001193125-26-122274 13944
2026-03-24 4 4 0001193125-26-122272 13944
2026-03-24 4 4 0001193125-26-122268 13980
2026-03-24 4 4 0001193125-26-122267 8285
2026-03-17 4 4 0001193125-26-111286 9255
2026-03-17 4 4 0001193125-26-111284 16059
2026-03-17 4 4 0001193125-26-111281 9098
2026-03-17 4 4 0001193125-26-111278 9094
2026-03-16 8-K 8-K 1.01,2.03,3.02,9.01 0001193125-26-108333 001-37923 26756698 34 1680696 1 1
2026-03-12 4 4 0001193125-26-104481 9101
2026-03-12 4 4 0001193125-26-104480 9097
2026-03-11 8-K 8-K 8.01,9.01 0001193125-26-101073 001-37923 26741524 34 205898 1 1
2026-02-20 4 4 0001193125-26-061712 9009
2026-02-20 4 4 0001193125-26-061710 8864
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000940594-26-000006 005-89674 26638583 34 10472
2026-02-12 10-K 10-K 0001193125-26-048957 001-37923 26627374 34 24441834 1 1
2026-02-12 8-K 8-K 2.02,9.01 0001193125-26-048873 001-37923 26626930 34 417292 1 1
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001562230-26-000001 005-89674 26602211 34 7499
2026-01-27 4 4 0001193125-26-024955 5106
2026-01-26 4 4 0001193125-26-022845 8852
2026-01-22 4 4 0001193125-26-019733 9734
2026-01-22 144 xsl144X01/primary_doc.xml 0001958244-26-000050 001-37923 26552476 33 6737
2026-01-22 144 xsl144X01/primary_doc.xml 0001950047-26-000625 001-37923 26551561 33 6133
2026-01-20 144 xsl144X01/primary_doc.xml 0001958244-26-000046 001-37923 26543804 33 12218
2026-01-12 8-K 8-K 8.01 0001193125-26-009880 001-37923 26524861 34 167512 1 1
2026-01-08 4 4 0001193125-26-007875 15815
2026-01-06 144 xsl144X01/primary_doc.xml 0001950047-26-000216 001-37923 26512728 33 5451
2025-12-23 4 4 0001193125-25-331162 8984
2025-12-22 4 4 0001193125-25-329010 5096
2025-12-22 144 xsl144X01/primary_doc.xml 0001950047-25-010601 001-37923 251592716 33 5362
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000940594-25-000008 005-89674 251483523 34 16378
2025-11-10 10-Q 10-Q 0001193125-25-273337 001-37923 251464493 34 9813878 1 1
2025-11-10 8-K 8-K 2.02,9.01 0001193125-25-273329 001-37923 251464468 34 428985 1 1
2025-11-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-106355 005-89674 251450255 34 13752
2025-10-20 4 4 0001193125-25-243819 9565
2025-10-15 4 4 0001193125-25-240438 9489
2025-10-15 4 4 0001193125-25-240437 8981
2025-10-15 8-K 8-K 8.01,9.01 0001193125-25-240282 001-37923 251395031 34 285391 1 1
2025-10-15 424B5 424B5 0001193125-25-240259 333-281262 251394942 33 3831743 1 1
2025-10-03 4 4 0001193125-25-230511 5389
2025-10-03 4 4 0001193125-25-230508 5380
2025-10-03 4 4 0001193125-25-230506 5399
2025-10-03 4 4 0001193125-25-230505 5378
2025-09-19 4 4 0001193125-25-209353 5308
2025-08-19 4 4 0001682019-25-000003 9358
2025-08-08 4 4 0001688192-25-000004 5109
2025-08-04 10-Q 10-Q 0000950170-25-102052 001-37923 251180791 34 11160906 1 1
2025-08-04 8-K 8-K 2.02,9.01 0000950170-25-102027 001-37923 251180570 34 420432 1 1
2025-07-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002963 005-89674 251132107 34 10912
2025-07-17 4 4 0000950170-25-096666 9499
2025-06-26 8-K 8-K 8.01 0000950170-25-090170 001-37923 251075044 34 160808 1 1
2025-06-10 3/A 3/A 0000950170-25-084490 5424
2025-06-09 8-K 8-K 5.03,5.07,9.01 0000950170-25-083799 001-37923 251034596 34 1048072 1 1
2025-06-06 4 4 0000950170-25-083298 5338
2025-06-06 4 4 0000950170-25-083289 5285
2025-06-06 4 4 0000950170-25-083274 5359
2025-06-06 4 4 0000950170-25-083273 5348
2025-06-06 4 4 0000950170-25-083272 5341
2025-06-06 4 4 0000950170-25-083271 5351
2025-06-06 4 4 0000950170-25-083270 5290
2025-06-06 4 4 0000950170-25-083269 5334
2025-06-06 4 4 0000950170-25-083268 5336
2025-06-06 4 4 0000950170-25-083267 5331
2025-06-06 3 3 0000950170-25-083255 20948
2025-06-03 4 4 0000950170-25-081362 5398
2025-06-03 4 4 0000950170-25-081361 5401
2025-05-30 4 4 0000950170-25-079822 8759
2025-05-19 424B5 424B5 0000950170-25-074553 333-281262 25965018 33 1270419 1 1
2025-05-19 8-K 8-K 1.01,8.01,9.01 0000950170-25-074428 001-37923 25964549 34 1153940 1 1
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-048312 005-89674 25943525 34 13547
2025-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001562230-25-000068 005-89674 25941820 34 7413
2025-05-06 10-Q 10-Q 0000950170-25-064468 001-37923 25917351 34 8364861 1 1
2025-05-06 8-K 8-K 2.02,9.01 0000950170-25-064435 001-37923 25917179 34 580247 1 1
2025-04-16 ARS ARS 0000950170-25-054744 001-37923 25843012 34 14501549
2025-04-16 DEFA14A DEFA14A 0000950170-25-054724 001-37923 25842955 34 12000422 1 1
2025-04-16 DEF 14A DEF 14A 0000950170-25-054711 001-37923 25842746 34 15428018 1 1
2025-04-03 PRE 14A PRE 14A 0000950170-25-050391 001-37923 25809520 34 15441564 1 1
2025-03-26 8-K 8-K 5.02,9.01 0000950170-25-045232 001-37923 25773310 34 174927 1 1
2025-03-24 4 4 0000950170-25-043975 9481
2025-03-24 4 4 0000950170-25-043974 9475
2025-03-24 4 4 0000950170-25-043973 8821
2025-03-24 4 4 0000950170-25-043972 8785
2025-03-18 4 4 0000950170-25-041470 7835
2025-03-18 4 4 0000950170-25-041471 13399
2025-03-18 4 4 0000950170-25-041469 7848
2025-03-18 4 4 0000950170-25-041468 7839
2025-03-18 4 4 0000950170-25-041467 7854
2025-03-12 4 4 0000950170-25-038216 14656
2025-03-12 4 4 0000950170-25-038215 13958
2025-03-12 4 4 0000950170-25-038214 14638
2025-02-28 4 4 0000950170-25-030181 4990
2025-02-21 4 4 0000950170-25-025000 5812
2025-02-19 4 4 0000950170-25-023387 9491
2025-02-19 4 4 0000950170-25-023385 11584
2025-02-19 4 4 0000950170-25-023386 13789
2025-02-18 144 xsl144X01/primary_doc.xml 0001958244-25-001197 001-37923 25636293 33 10142
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-013688 005-89674 25625061 34 7041
2025-02-11 10-K 10-K 0000950170-25-017899 001-37923 25609891 34 26836831 1 1
2025-02-11 8-K 8-K 2.02,9.01 0000950170-25-017879 001-37923 25609747 34 398296 1 1
2025-01-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-002717 005-89674 25524519 34 7010
2024-12-27 4 4 0000950170-24-140846 7362
2024-12-10 SC 13G/A SC 13G/A 0001104659-24-127131 005-89674 241537881 34 46781
2024-12-04 4 4 0000950170-24-133373 5812
2024-11-13 4 4 0000950170-24-126521 7713
2024-11-12 144 xsl144X01/primary_doc.xml 0001958244-24-005724 001-37923 241443567 33 15022
2024-11-05 10-Q 10-Q 0000950170-24-121105 001-37923 241425947 34 7231871 1 1
2024-11-05 8-K 8-K 2.02,9.01 0000950170-24-121103 001-37923 241425932 34 360788 1 1
2024-10-18 4 4 0000950170-24-115696 7684
2024-10-18 4 4 0000950170-24-115695 5329
2024-10-18 4 4 0000950170-24-115697 5325
2024-10-18 4 4 0000950170-24-115694 7874
2024-10-18 4 4 0000950170-24-115693 7665
2024-10-15 4 4 0000950170-24-114787 8915
2024-10-15 4 4 0000950170-24-114786 9491
2024-08-12 4 4 0000950170-24-095615 5293
2024-08-05 S-3ASR FORM S-3ASR 0000950123-24-007171 333-281262 241176126 33 6777851 1 1
2024-08-05 S-8 S-8 0000950170-24-090818 333-281247 241175702 33 385048 1 1
2024-08-05 10-Q 10-Q 0000950170-24-090746 001-37923 241174845 34 7041145 1 1
2024-08-05 8-K 8-K 2.02,9.01 0000950170-24-090727 001-37923 241174708 34 359553 1 1
2024-06-24 4 4 0000950170-24-076916 9293
2024-06-03 8-K 8-K 5.02,5.03,5.07,9.01 0000950170-24-067660 001-37923 241012051 34 931431 1 1
2024-05-31 4 4 0000950170-24-067402 5450
2024-05-31 4 4 0000950170-24-067400 33032
2024-05-31 4 4 0000950170-24-067329 5340
2024-05-31 4 4 0000950170-24-067326 5342
2024-05-31 4 4 0000950170-24-067324 5296
2024-05-31 4 4 0000950170-24-067322 5166
2024-05-31 4 4 0000950170-24-067327 5337
2024-05-31 4 4 0000950170-24-067323 5354
2024-05-31 4 4 0000950170-24-067321 5357
2024-05-30 3 3 0000950170-24-066655 18539
2024-05-30 3 3 0000950170-24-066648 17236
2024-05-29 4 4 0000950170-24-065943 7769
2024-05-28 3 3 0000950170-24-065202 18868
2024-05-24 4 4 0000950170-24-064607 5334
2024-05-23 3 3 0000950170-24-063974 41823
2024-05-23 8-K FORM 8-K 5.02,9.01 0000950123-24-005877 001-37923 24975256 34 338527 1 1
2024-05-08 10-Q 10-Q 0000950170-24-055719 001-37923 24926499 34 6168612 1 1
2024-05-08 8-K 8-K 2.02,9.01 0000950170-24-055689 001-37923 24926262 34 304353 1 1
2024-04-17 4 4 0000950170-24-045196 11343
2024-04-15 144 xsl144X01/primary_doc.xml 0001950047-24-003074 001-37923 24844935 33 9595
2024-04-10 SC 13G/A SEC SCHEDULE 13G 0001562230-24-000015 005-89674 24834757 34 18229
2024-04-09 ARS ARS 0001193125-24-090912 001-37923 24833273 34 2836660
2024-04-09 DEFA14A DEFA14A 0000950170-24-043026 001-37923 24833238 34 1911386
2024-04-09 DEF 14A DEF 14A 0000950170-24-043025 001-37923 24833223 34 6262259 1 1
2024-03-27 PRE 14A PRE 14A 0000950170-24-037243 001-37923 24791253 34 4998676 1 1
2024-03-22 4 4 0000950170-24-035517 7783
2024-03-22 4 4 0000950170-24-035516 7761
2024-03-22 4 4 0000950170-24-035515 7777
2024-03-22 144 xsl144X01/primary_doc.xml 0001950047-24-002638 001-37923 24775127 33 4636
2024-03-18 4 4 0000950170-24-032990 8755
2024-03-18 4 4 0000950170-24-032989 11347
2024-03-15 144 xsl144X01/primary_doc.xml 0001950047-24-002408 001-37923 24755502 33 8908
2024-03-12 4 4 0000950170-24-030190 13944
2024-03-12 4 4 0000950170-24-030189 14643
2024-02-27 4 4 0000950170-24-021510 9488
2024-02-21 4 4 0000950170-24-018175 8969
2024-02-21 4 4 0000950170-24-018174 9490
2024-02-21 10-K 10-K 0000950170-24-017571 001-37923 24656410 34 23219672 1 1
2024-02-21 8-K 8-K 2.02,9.01 0000950170-24-017568 001-37923 24656404 34 357545 1 1
2024-02-16 4 4 0000950170-24-016574 13250
2024-02-15 144 xsl144X01/primary_doc.xml 0001950047-24-001007 001-37923 24644277 33 6167
2024-02-13 8-K 8-K 1.01,9.01 0001193125-24-033973 001-37923 24630109 34 360688 1 1
2024-02-13 424B5 424B5 0001193125-24-032975 333-258274 24622730 33 556781
2024-02-13 8-K 8-K 8.01 0001193125-24-032825 001-37923 24622494 34 140430 1 1
2024-02-12 SC 13G/A SC 13G/A 0001140361-24-007107 005-89674 24621835 34 72206
2024-02-09 SC 13G/A SEC SCHEDULE 13G 0001422848-24-000101 005-89674 24616594 34 18397
2024-02-05 SC 13G/A AMENDMENT NO. 4 0001214659-24-001842 005-89674 24593842 34 63559
2024-01-31 4 4 0000950170-24-009505 11754
2024-01-29 144 xsl144X01/primary_doc.xml 0001950047-24-000492 001-37923 24573716 33 5480
2024-01-29 SC 13G/A SC 13G/A 0001104659-24-007685 005-89674 24573539 34 46840
2024-01-18 4 4 0000950170-24-005492 9660
2024-01-16 144 xsl144X01/primary_doc.xml 0001950047-24-000339 001-37923 24535822 33 4793
2024-01-16 8-K 8-K 8.01 0000950170-24-004616 001-37923 24535275 34 148538 1 1
2024-01-10 SC 13G/A SC 13G/A 0001104659-24-002893 005-89674 24525562 34 44867
2023-12-19 8-K 8-K 5.02 0000950170-23-071505 001-37923 231497596 34 152300 1 1
2023-12-15 8-K 8-K 8.01 0000950170-23-070582 001-37923 231488939 34 152459 1 1
2023-12-13 8-K 8-K 1.01,9.01 0000950170-23-069892 001-37923 231483105 34 248786 1 1
2023-12-08 8-K 8-K 8.01 0000950170-23-068974 001-37923 231474775 34 153450 1 1
2023-12-04 8-K 8-K 8.01 0000950170-23-067774 001-37923 231463438 34 164025 1 1
2023-11-16 8-K 8-K 8.01 0000950170-23-064341 001-37923 231412410 34 160276 1 1
2023-11-06 10-Q 10-Q 0000950170-23-059476 001-37923 231380494 34 8178652 1 1
2023-11-06 8-K 8-K 2.02,9.01 0000950170-23-059461 001-37923 231380407 34 421832 1 1
2023-10-17 4 4 0000950170-23-053820 5179
2023-10-17 4 4 0000950170-23-053819 5054
2023-10-17 4 4 0000950170-23-053818 7721
2023-10-17 4 4 0000950170-23-053817 7664
2023-09-07 8-K 8-K 5.02,8.01,9.01 0000950170-23-046889 001-37923 231241042 34 196040 1 1
2023-08-07 S-8 S-8 0000950170-23-039087 333-273764 231147868 33 332100
2023-08-07 10-Q 10-Q 0000950170-23-039075 001-37923 231147766 34 8627509 1 1
2023-08-07 8-K 8-K 2.02,9.01 0000950170-23-039057 001-37923 231147639 34 459818 1 1
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035992 19578
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035990 5447
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035980 5520
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035978 5509
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035977 5468
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035975 5529
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035974 5508
2023-06-09 8-K 8-K 5.02,5.03,5.07,9.01 0000950170-23-027277 001-37923 231005729 34 1285353 1 1
2023-06-09 8-K 8-K 7.01,8.01,9.01 0000950170-23-027129 001-37923 231003854 34 338857 1 1
2023-06-01 4 FORM 4 SUBMISSION 0001209191-23-033394 15402
2023-05-30 144 xsl144X01/primary_doc.xml 0001950047-23-001028 001-37923 23977085 33 6739
2023-05-25 4 FORM 4 SUBMISSION 0001209191-23-032250 9367
2023-05-18 DEFA14A DEFA14A 0000950170-23-023039 001-37923 23936287 34 38141
2023-05-10 144 xsl144X01/primary_doc.xml 0001950047-23-000497 001-37923 23905925 33 4463
2023-05-08 10-Q 10-Q 0000950170-23-018811 001-37923 23897850 34 7917248 1 1
2023-05-08 8-K 8-K 2.02,9.01 0000950170-23-018790 001-37923 23897731 34 376895 1 1
2023-04-27 4 FORM 4 SUBMISSION 0001209191-23-025901 11283
2023-04-26 ARS ARS 0000950170-23-014870 001-37923 23850359 34 8162550
2023-04-26 DEFA14A DEFA14A 0000950170-23-014847 001-37923 23850138 34 2462955
2023-04-26 DEF 14A DEF 14A 0000950170-23-014831 001-37923 23850039 34 11452966 1 1
2023-04-25 144 xsl144X01/primary_doc.xml 0001950047-23-000230 001-37923 23845240 33 8103
2023-04-11 SC 13G/A SC 13G/A 0001104659-23-043733 005-89674 23812217 34 42951
2023-04-10 PRE 14A PRE 14A 0000950170-23-012305 001-37923 23811559 34 10068906 1 1
2023-04-03 8-K 8-K 7.01,8.01,9.01 0000950170-23-011476 001-37923 23790718 34 233688 1 1
2023-03-31 4 FORM 4 SUBMISSION 0001209191-23-021911 11266
2023-03-29 8-K 8-K 5.02,9.01 0000950170-23-010439 001-37923 23771825 34 193998 1 1
2023-03-27 8-K 8-K 1.01,7.01,9.01 0000950170-23-009861 001-37923 23761479 34 875697 1 1
2023-03-14 4 FORM 4 SUBMISSION 0001209191-23-018571 8103
2023-03-14 4 FORM 4 SUBMISSION 0001209191-23-018566 19745
2023-03-14 4 FORM 4 SUBMISSION 0001209191-23-018564 19740
2023-03-14 4 FORM 4 SUBMISSION 0001209191-23-018561 8070
2023-03-14 3 FORM 3 SUBMISSION 0001209191-23-018559 7012
2023-03-14 8-K 8-K 5.02,9.01 0000950170-23-007716 001-37923 23729243 34 416325 1 1
2023-03-01 4 FORM 4 SUBMISSION 0001209191-23-014273 13299
2023-02-22 4 FORM 4 SUBMISSION 0001209191-23-011790 9186
2023-02-22 4 FORM 4 SUBMISSION 0001209191-23-011782 9238
2023-02-22 4 FORM 4 SUBMISSION 0001209191-23-011777 9242
2023-02-21 10-K 10-K 0000950170-23-003441 001-37923 23648233 34 24189204 1 1
2023-02-21 8-K 8-K 2.02,9.01 0000950170-23-003436 001-37923 23648094 34 454739 1 1
2023-02-13 SC 13G SEC SCHEDULE 13G 0001562230-23-000029 005-89674 23618024 34 18306
2023-02-10 SC 13G/A SC 13G/A 0001104659-23-018250 005-89674 23609822 34 44591
2023-02-10 SC 13G/A SC 13G/A 0001140361-23-005799 005-89674 23609180 34 67887
2023-02-03 SC 13G/A AMENDMENT NO. 3 0001214659-23-001563 005-89674 23583651 34 63457
2023-01-31 4 FORM 4 SUBMISSION 0001209191-23-005769 11234
2022-12-30 4 FORM 4 SUBMISSION 0001209191-22-063026 11235
2022-12-08 4 FORM 4 SUBMISSION 0001209191-22-060387 7029
2022-12-06 4 FORM 4 SUBMISSION 0001209191-22-060093 9227
2022-12-06 4 FORM 4 SUBMISSION 0001209191-22-060090 9404
2022-11-30 4 FORM 4 SUBMISSION 0001209191-22-059060 13297
2022-11-01 10-Q 10-Q 0000950170-22-020845 001-37923 221350359 34 9646082 1 1
2022-11-01 8-K 8-K 2.02,9.01 0000950170-22-020834 001-37923 221350222 34 456303 1 1
2022-10-28 4 FORM 4 SUBMISSION 0001209191-22-054838 19259
2022-10-27 8-K 8-K 5.02,9.01 0000950170-22-020257 001-37923 221335031 34 202614 1 1
2022-10-18 4 FORM 4 SUBMISSION 0001209191-22-053989 9316
2022-10-12 4 FORM 4 SUBMISSION 0001209191-22-053498 5347
2022-10-12 4 FORM 4 SUBMISSION 0001209191-22-053496 5381
2022-10-12 4 FORM 4 SUBMISSION 0001209191-22-053494 5401
2022-09-30 4 FORM 4 SUBMISSION 0001209191-22-051675 11224
2022-09-27 8-K 8-K 7.01,8.01,9.01 0000950170-22-018864 001-37923 221267279 34 243527 1 1
2022-08-31 4 FORM 4 SUBMISSION 0001209191-22-048166 12788
2022-08-18 4 FORM 4 SUBMISSION 0001209191-22-046714 9492
2022-08-18 4 FORM 4 SUBMISSION 0001209191-22-046711 8790
2022-08-18 4 FORM 4 SUBMISSION 0001209191-22-046709 9556
2022-08-18 4 FORM 4 SUBMISSION 0001209191-22-046707 9550
2022-08-08 S-8 S-8 0000950170-22-015510 333-266636 221144343 33 330628
2022-08-08 10-Q 10-Q 0000950170-22-015256 001-37923 221142635 34 9443809 1 1
2022-08-08 8-K 8-K 2.02,9.01 0000950170-22-015255 001-37923 221142624 34 452474 1 1
2022-07-29 4 FORM 4 SUBMISSION 0001209191-22-043553 23372
2022-07-13 UPLOAD filename1.pdf 0000000000-22-007379 39568
2022-07-01 4 FORM 4 SUBMISSION 0001209191-22-040343 15230
2022-06-23 CORRESP filename1.htm 0001193125-22-180372 24737
2022-06-21 8-K 8-K 8.01,9.01 0000950170-22-011912 001-37923 221028909 34 842893 1 1
2022-06-13 UPLOAD filename1.pdf 0000000000-22-006457 44342
2022-06-13 8-K 8-K 5.02,5.03,5.07,9.01 0000950170-22-011570 001-37923 221012332 34 1051399 1 1
2022-06-13 8-K 8-K 7.01,8.01,9.01 0000950170-22-011518 001-37923 221010728 34 1952029 1 1
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036055 5415
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036053 9557
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036048 9548
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036045 9501
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036042 9536
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036037 5264
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036036 9578
2022-06-10 4 FORM 4 SUBMISSION 0001209191-22-036031 9551
2022-06-10 3 FORM 3 SUBMISSION 0001209191-22-036027 6896
2022-05-24 4 FORM 4 SUBMISSION 0001209191-22-031705 8070
2022-05-23 3 FORM 3 SUBMISSION 0001209191-22-031397 7037
2022-05-16 8-K 8-K 7.01,9.01 0000950170-22-010081 001-37923 22929176 34 199627 1 1
2022-05-12 8-K 8-K 7.01,8.01,9.01 0000950170-22-009648 001-37923 22917719 34 321401 1 1
2022-05-09 10-Q 10-Q 0000950170-22-008495 001-37923 22905060 34 7817579 1 1
2022-05-09 8-K 8-K 2.02,9.01 0000950170-22-008479 001-37923 22904884 34 353008 1 1
2022-04-25 DEFA14A DEFA14A 0000950170-22-006101 001-37923 22850014 34 2105452
2022-04-25 DEF 14A DEF 14A 0000950170-22-006098 001-37923 22849964 34 4702893
2022-04-12 PRE 14A PRE 14A 0000950170-22-005617 001-37923 22822570 34 4506339
2022-03-14 4 FORM 4 SUBMISSION 0001209191-22-018613 14788
2022-03-14 4 FORM 4 SUBMISSION 0001209191-22-018611 14783
2022-03-14 4 FORM 4 SUBMISSION 0001209191-22-018609 14963
2022-02-22 4 FORM 4 SUBMISSION 0001209191-22-011841 8034
2022-02-22 4 FORM 4 SUBMISSION 0001209191-22-011840 8083
2022-02-22 4 FORM 4 SUBMISSION 0001209191-22-011838 8083
2022-02-22 4 FORM 4 SUBMISSION 0001209191-22-011836 8088
2022-02-15 10-K 10-K 0000950170-22-001282 001-37923 22639328 34 27356305 1 1
2022-02-15 8-K 8-K 2.02,9.01 0000950170-22-001279 001-37923 22639188 34 419862 1 1
2022-02-14 SC 13G/A SC13G/A 0001140361-22-005027 005-89674 22624446 34 64355
2022-02-11 SC 13G/A SEC SCHEDULE 13G 0001562230-22-000014 005-89674 22617865 34 18226
2022-02-09 SC 13G/A SC 13G/A 0001104659-22-016142 005-89674 22605874 34 41156
2022-02-04 SC 13G/A AMENDMENT NO. 2 0001214659-22-001841 005-89674 22590805 34 63479
2021-12-22 4 FORM 4 SUBMISSION 0001209191-21-070994 7023
2021-12-20 8-K 8-K 5.02 0001193125-21-361760 001-37923 211503685 34 138612 1 1
2021-12-07 4 FORM 4 SUBMISSION 0001209191-21-068456 9221
2021-12-07 4 FORM 4 SUBMISSION 0001209191-21-068455 9222
2021-12-07 4 FORM 4 SUBMISSION 0001209191-21-068454 9204
2021-12-07 4 FORM 4 SUBMISSION 0001209191-21-068453 9225
2021-12-03 4 FORM 4 SUBMISSION 0001209191-21-068014 6954
2021-12-03 4 FORM 4 SUBMISSION 0001209191-21-068013 5093
2021-11-22 8-K 8-K 7.01,9.01 0001193125-21-336045 001-37923 211430265 34 158108 1 1
2021-11-03 10-Q 10-Q 0000950170-21-002825 001-37923 211375474 34 9809458 1 1
2021-11-03 8-K 8-K 2.02,9.01 0000950170-21-002821 001-37923 211375368 34 409311 1 1
2021-10-18 4 FORM 4 SUBMISSION 0001209191-21-060778 5393
2021-10-18 4 FORM 4 SUBMISSION 0001209191-21-060777 8069
2021-10-18 4 FORM 4 SUBMISSION 0001209191-21-060776 5388
2021-10-18 4 FORM 4 SUBMISSION 0001209191-21-060775 9429
2021-10-18 4 FORM 4 SUBMISSION 0001209191-21-060774 5370
2021-10-15 3 FORM 3 SUBMISSION 0001209191-21-060641 6837
2021-10-14 8-K 8-K 5.02,9.01 0001193125-21-298277 001-37923 211322480 34 261199 1 1
2021-10-12 8-K 8-K 7.01,8.01,9.01 0001193125-21-296954 001-37923 211319060 34 5846649 1 1
2021-09-14 4 FORM 4 SUBMISSION 0001209191-21-056093 9065
2021-09-14 4 FORM 4 SUBMISSION 0001209191-21-056092 9059
2021-09-10 SC 13G/A SC 13G/A 0001104659-21-114593 005-89674 211246819 34 48169
2021-09-03 4 FORM 4 SUBMISSION 0001209191-21-054903 5095
2021-08-10 4 FORM 4 SUBMISSION 0001209191-21-050719 11235
2021-08-10 SC 13G/A SEC SCHEDULE 13G 0001562230-21-000117 005-89674 211159158 34 18238
2021-08-06 4 FORM 4 SUBMISSION 0001209191-21-050256 23167
2021-07-29 S-3ASR S-3ASR 0001193125-21-229395 333-258274 211128615 33 1269525
2021-07-29 10-Q 10-Q 0001564590-21-039178 001-37923 211128127 34 9268485 1 1
2021-07-29 8-K 8-K 2.02,9.01 0001564590-21-039171 001-37923 211127955 34 408205 1 1
2021-07-21 4 FORM 4 SUBMISSION 0000899243-21-029271 21564
2021-07-01 4 FORM 4 SUBMISSION 0001209191-21-044516 4683
2021-06-30 4 FORM 4 SUBMISSION 0000899243-21-026801 58159
2021-06-30 4 FORM 4 SUBMISSION 0000899243-21-026800 31703
2021-06-30 4 FORM 4 SUBMISSION 0001209191-21-044012 4683
2021-06-23 4 FORM 4 SUBMISSION 0001209191-21-042811 15035
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041602 13287
2021-06-15 4 FORM 4 SUBMISSION 0000899243-21-023880 23247
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040332 5417
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040297 5477
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040296 5466
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040295 5425
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040294 5462
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040292 5475
2021-06-14 4 FORM 4 SUBMISSION 0001209191-21-040291 5277
2021-06-14 3 FORM 3 SUBMISSION 0001209191-21-040288 6997

Latest XBRL company facts

One latest value per concept from companyfacts (307 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 97.00M 2026-10-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
dei EntityPublicFloat Entity Public Float USD 4.10B 2025-06-30 2025 FY 10-K 2026-02-12 0001193125-26-048957
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 54.68 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001193125-26-165158
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 5.86M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001193125-26-165158
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.60M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001193125-26-165158
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 119.92 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001193125-26-165158
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 21.97M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001193125-26-165158
ecd PeoTotalCompAmt PeoTotalCompAmt USD 7.68M 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001193125-26-165158
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 34.25 2025-01-01 2025-12-31 DEF 14A 2026-04-21 0001193125-26-165158
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 20.59M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap AccountsReceivableRelatedPartiesCurrent Accounts Receivable, Related Parties, Current USD 0 2019-12-31 2019 FY 10-K 2020-02-12 0001564590-20-004355
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD -14.11M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-15 0000950170-22-001282
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 82.02M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 3.32M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 103.80M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -14.08M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 3.93B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 17.96M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 51.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 1.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 16.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap Assets Assets USD 2.56B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap AssetsCurrent Assets, Current USD 2.29B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 72,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 14.25M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 2.08B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 2.06B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 394,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap Cash Cash USD 456.65M 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 192.03M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 6.78M 2021-12-31 2021 FY 10-K 2022-02-15 0000950170-22-001282
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -75.76M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004920
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 344.93M 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011470
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 200.03M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -159.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap CashCollateralForBorrowedSecurities Cash Collateral for Borrowed Securities USD 377,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 30.39M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 9.37M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share CHF/shares 0.03 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 144.45M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 96.93M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 96.86M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap CommonStockValue Common Stock, Value, Issued USD 3.15M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -344.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 300,000 2020-12-31 2020 FY 10-K 2021-02-16 0001564590-21-006074
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 12.30M 2024-12-31 2024 FY 10-K 2025-02-11 0000950170-25-017899
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 2.55M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 185.56M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 38.34M 2015-12-31 2016 FY 10-K 2017-03-10 0001564590-17-003977
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 1.66M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-21 0000950170-24-017571
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 2.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 1.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 61.93M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 600.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.022 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 13.07M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 4.02B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 1.59T 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 1.59T 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance shares 17.69M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 933,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -2,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 915,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 66.22M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 1.20M 2018-12-31 2020 FY 10-K 2021-02-16 0001564590-21-006074
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 11.05M 2018-12-31 2019 FY 10-K 2020-02-12 0001564590-20-004355
us-gaap DeferredRevenue Deferred Revenue USD 1.90M 2020-12-31 2020 FY 10-K 2021-02-16 0001564590-21-006074
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 63.61M 2016-09-30 2016 Q3 10-Q 2016-11-22 0001193125-16-774104
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 57.86M 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011470
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -18,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 86,000 2020-12-31 2021 FY 10-K 2022-02-15 0000950170-22-001282
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 410.49M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 11,000 2019-12-31 2020 FY 10-K 2021-02-16 0001564590-21-006074
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 65.09M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 241.46M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 0 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 4.04B 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 9.40M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 12.34M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 77.90M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 18.80M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 3.39M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 3.30M 2018-12-31 2019 FY 10-K 2020-02-12 0001564590-20-004355
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 345.39M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 1.13M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 0 2024-12-31 2024 FY 10-K 2025-02-11 0000950170-25-017899
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 37,000 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 30.13M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap DeferredTaxLiabilitiesTaxDeferredIncome Deferred Tax Liabilities, Tax Deferred Income USD 20,000 2019-12-31 2020 FY 10-K 2021-02-16 0001564590-21-006074
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 1.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap Depreciation Depreciation USD 12.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 12.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap Dividends Dividends USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.38 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -2.44 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-07-27 0001564590-20-033602
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.38 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.006 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.119 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.152 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.01 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.004 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.011 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.027 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations USD 12,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011470
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -20,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 11.43M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 72.00M 2023-12-31 2023 FY 10-K 2024-02-21 0000950170-24-017571
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 80.30M 2023-12-31 2023 FY 10-K 2024-02-21 0000950170-24-017571
us-gaap EquityMethodInvestments Equity Method Investments USD 36.50M 2016-12-31 2020 Q3 10-Q 2020-10-28 0001564590-20-048169
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueAmount Equity Securities without Readily Determinable Fair Value, Amount USD 31.90M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap FairValueNetAssetLiability Fair Value, Net Asset (Liability) USD 16.00M 2021-12-31 2021 FY 10-K 2022-02-15 0000950170-22-001282
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2024-12-31 2024 FY 10-K 2025-02-11 0000950170-25-017899
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD 9,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -28,000 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022720
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 11.48M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 52.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 32.53M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -323.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -610.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -348.06M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-16 0001564590-21-006074
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -5.47M 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-15 0000950170-22-001282
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 2.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 1.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 2.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -13.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -244,000 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-07 0001564590-18-019945
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 3.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 5.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 4,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004920
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 413,000 2016-09-30 2016 Q3 10-Q 2016-11-22 0001193125-16-774104
us-gaap InterestExpenseDebt Interest Expense, Debt USD 7.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap InterestExpenseDebtExcludingAmortization Interest Expense, Debt, Excluding Amortization USD 5.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -8.05M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 0 2016-12-31 2016 FY 10-K 2017-03-10 0001564590-17-003977
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 104.30M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-11 0000950170-25-017899
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure Investments in Affiliates, Subsidiaries, Associates, and Joint Ventures, Fair Value Disclosure USD 106.30M 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028026
us-gaap LeaseCost Lease, Cost USD 36.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 265.57M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 123.53M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 29.68M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 28.04M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 27.31M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 28.21M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 28.80M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 2.00M 2019-09-30 2019 Q3 10-Q 2019-10-28 0001564590-19-038024
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 58.83M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap Liabilities Liabilities USD 908.34M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 2.56B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap LiabilitiesCurrent Liabilities, Current USD 140.96M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap LiabilityForUncertainTaxPositionsNoncurrent Liability for Uncertainty in Income Taxes, Noncurrent USD 700,000 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap LongTermDebt Long-term Debt USD 586.93M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 18.20M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap LossContingencyEstimateOfPossibleLoss Loss Contingency, Estimate of Possible Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap MarketableSecurities Marketable Securities USD 161.60M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 2.08B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 4.02M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 8.20M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-06 0000950170-25-064468
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD -27,000 2015-12-31 2016 FY 10-K 2017-03-10 0001564590-17-003977
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 603.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 125.25M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011470
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -480.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -555,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011470
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -282.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -22.69M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011470
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -325.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -25,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 66.86M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-12 0001564590-20-004355
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 66.86M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-12 0001564590-20-004355
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 53.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap OperatingExpenses Operating Expenses USD 401.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -377.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap OperatingLeaseCost Operating Lease, Cost USD 23.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 206.75M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 18.68M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 174.21M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap OperatingLeasePayments Operating Lease, Payments USD 29.22M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 122.61M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 50.58M 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 6.28M 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 5.86M 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 5.87M 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 7.07M 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 6.87M 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 18.64M 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 1.29M 2015-12-31 2016 Q3 10-Q 2016-11-22 0001193125-16-774104
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 5.70M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.059 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 524,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 32.78M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 0 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-15 0000950170-22-001282
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -20,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 8,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-04-29 0001564590-19-013720
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -9.45M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -18.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 17.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 6.24M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap OtherNoncashExpense Other Noncash Expense USD 979,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-28 0001564590-20-048169
us-gaap OtherNoncashIncome Other Noncash Income USD 169,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-12 0001564590-20-004355
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 7.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 3.81M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-03 0000950170-21-002825
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 53.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 8.05M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted USD 0 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-22 0001193125-16-774104
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 1.81M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 57,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-16 0001564590-21-006074
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 14.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 2.68M 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022720
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 500,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-12 0001564590-20-004355
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 100,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap PaymentsToAcquireEquitySecuritiesFvNi PaymentsToAcquireEquitySecuritiesFvNi USD 22.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 1.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 1.27B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 0 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004920
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004920
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2017-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004920
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 12.53M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 35.01M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 54.06M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004920
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD -722,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 35.00M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004920
us-gaap ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt USD 600.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 18.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 588.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ProceedsFromSaleOfEquitySecuritiesFvNi ProceedsFromSaleOfEquitySecuritiesFvNi USD 702,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 7.62M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-07-27 0001564590-20-033602
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 279.00M 2024-02-01 2024-02-29 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -325.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap PropertyPlantAndEquipmentFairValueDisclosure Property, Plant, and Equipment, Fair Value Disclosure USD 9.34M 2021-12-31 2021 FY 10-K 2022-02-15 0000950170-22-001282
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 208.10M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 104.30M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 207.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 3.16M 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 3.16M 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 3.89M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 7.63M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -2.27B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 24.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 746,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-02-15 0000950170-22-001282
us-gaap Revenues Revenues USD 157,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-04-28 0001564590-20-019278
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 51.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 44,273 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 251,500 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 327,342 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 246,286 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.609 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 0.692 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-10-28 0001564590-19-038024
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 31.45M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 4.77M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 57.95 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 15.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 552,393 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 65.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 908,831 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 28.51 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 42.27M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 6.65M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 56.07 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 42.27M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 6.65M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 56.07 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 39.92 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 47.88 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 46,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.65B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 392.19M 2018-12-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 3.33 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-10 0001564590-17-003977
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 457,074 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 275.32M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 12,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 3.75M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap StockIssuedDuringPeriodValueTreasuryStockReissued Stock Issued During Period, Value, Treasury Stock Reissued USD 889,000 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-21 0000950170-23-003441
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 170,689 2016-10-01 2016-10-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 0 2016-10-01 2016-10-31 2018 FY 10-K 2019-02-25 0001564590-19-004115
us-gaap SubleaseIncome Sublease Income USD 930,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 132,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share CHF 0.03 2016-09-30 2016 Q3 10-Q 2016-11-22 0001193125-16-774104
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 18.84M 2015-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004920
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 18.84M 2015-12-31 2017 FY 10-K 2018-03-08 0001564590-18-004920
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 75,316 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap TreasuryStockShares Treasury Stock, Shares shares 180,316 2023-03-31 2023 Q1 10-Q 2023-05-08 0000950170-23-018811
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 170,689 2016-10-30 2016-10-31 2017 FY 10-K 2018-03-08 0001564590-18-004920
us-gaap TreasuryStockValue Treasury Stock, Value USD 60,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 57,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-16 0001564590-21-006074
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 50.71M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 2.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2023-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 2.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 51,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 46.70M 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 62.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap VariableLeaseCost Variable Lease, Cost USD 13.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-12 0001193125-26-048957
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 96.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 61.13M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-07-27 0001564590-20-033602
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 96.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001193125-26-443665

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →